Non HDL cholesterol
Clinical Relevance of Non-HDL Cholesterol in Patients With Diabetes
5
Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population
8
Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease
7
Family history of cardiovascular disease and non-HDL cholesterol in prepubescent non-obese children
6
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)
6
Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
14
Clinical Utility of C-Reactive Protein, NON-HDL Cholesterol and Lipid Ratios in Patients With Stroke
6
A Study on Significance of Non-HDL Cholesterol and Its relation with Cardiovascular Risk in Diabetic Population at GVMCH, Vellore
102
The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis
6
Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study
8
Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
6
Evaluation of Non-HDL-Cholesterol/HDL-cholesterol ratio as a predictor of coronary artery disease
8
RESEARCH ARTICLE Status of non-HDL-cholesterol and LDL-cholesterol among subjects with and without metabolic syndrome
5
Non-HDL Cholesterol Levels in Childhood and Carotid Intima-Media Thickness in Adulthood
11
Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population
8
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
7
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
12
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
10
Raising HDL cholesterol in women
11
CiteSeerX — Inversely Correlated With HDL Cholesterol and
9